LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy(University of Michigan), Joshi J. Alumkal(University of Michigan)JCI InsightJuly 13, 202310.1172/jci.insight.167440Cited by 40SaveCiteExport RISWatch citationsRelated PapersAntitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study|The Lancet|2010|1.1kTranscriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity|Nature Communications|2022|59Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer|Scientific Reports|2019|36